Boston-based Longwood Founders Management has set out to raise a $90 million third fund, and Shoreline Venture Management is targeting $100 million for its third fund, according to filings with the Securities and Exchange Commission.
Healthcare-focused Longwood, an investor in Calithera Biosciences Inc, which went public last fall, is seeking $90 million, according to a regulatory filing. The firm raised $66.66 million for its previous fund, which closed in 2014, according to data from Thomson Reuters. Its inaugural fund raised $86.93 million in 2010.
San Mateo, Calif.-based Shoreline, which focuses on seed-stage and early-stage healthcare and software deals, has already raised $3.9 million from 19 investors, according to a regulatory filing. Exits from its previous fund include Layer 7 Technologies, Callixa and Health Hero Noetwork. The firm’s website already lists Seattle-based Blab, a provider of predictive social analytics, as a portfolio company in its third fund.